aluates Reports

$ 0.0

Automative

Global Peripheral Drug-eluting Balloon Market Research Report 2026

Published Date: 2026-01-22

Report Code: QYRE-Auto-38W10443

Global Peripheral Drug eluting Balloon Market Research Report 2022

BUY CHAPTERS

Global Peripheral Drug-eluting Balloon Market Research Report 2026

Code: QYRE-Auto-38W10443

Report

2026-01-22

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

Acotec

Peripheral Drug-eluting Balloon Market Size

The global Peripheral Drug-eluting Balloon market was valued at US$ 811 million in 2025 and is anticipated to reach US$ 1775 million by 2032, at a CAGR of 11.7% from 2026 to 2032.

Peripheral Drug-eluting Balloon Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Peripheral Drug-eluting Balloon competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Peripheral drug-eluting balloons (often referred to as peripheral drug-coated balloons, DCBs) are endovascular angioplasty balloons designed for peripheral arteries (commonly femoropopliteal segments), coated with an antiproliferative drug (typically paclitaxel or “limus” agents) plus an excipient/carrier system. During inflation, they provide immediate lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is “leave nothing behind,” aiming to avoid the long-term burden of permanent implants and preserve flexibility for future revascularization, increasingly combined with lesion preparation and intravascular imaging to enable more repeatable peripheral vascular repair pathways.In 2025, global Peripheral drug-eluting balloons production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.

Opportunities are anchored in the long-term shift toward minimally invasive, repair-centric peripheral interventions. A clearer safety boundary has strengthened adoption confidence: the U.S. FDA’s updated communication on paclitaxel-coated devices for PAD states that the totality of available evidence does not support an increased mortality risk, enabling more actionable hospital governance and pathway standardization. In parallel, leading companies explicitly position peripheral drug-coated balloons within their core peripheral intervention portfolios in annual reporting, signaling a transition from selective use to routine toolset adoption with ongoing room for technology iteration and category expansion.

The competitive bar is shifting from “availability” to “scalable reproducibility and compliant delivery.” As drug–device combination products, peripheral DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and shelf-life stability—where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment and procurement reforms intensify the need to balance quality systems, supply assurance, and cost efficiency. In China, the National Healthcare Security Administration published the winning results for the national procurement of drug-coated balloons on January 14, 2026, accelerating a more rules-based, scale-driven market phase.

Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in peripheral disease elevate the importance of integrated optimization—lesion preparation, drug-transfer efficiency, and durable patency—driving more routine combination of DCBs with plaque-modification tools, specialty scoring balloons, and intravascular imaging (IVUS/OCT). Procurement implementation further encourages hospitals to formalize compliant pathways and device bundles, shifting growth from “operator preference–driven” to “pathway management–driven” adoption.

Upstream differentiation is ultimately an integrated “materials–coating–validation” capability. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. With procurement pressure and global compliance expectations in parallel, suppliers are increasingly evaluated on medical-grade traceability, clean manufacturing, and change control. The ability to industrialize coating consistency, yield, and batch-release stability as a platform capability directly determines scalable delivery efficiency and brand credibility.

This report delivers a comprehensive overview of the global Peripheral Drug-eluting Balloon market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Peripheral Drug-eluting Balloon. The Peripheral Drug-eluting Balloon market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Peripheral Drug-eluting Balloon market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Peripheral Drug-eluting Balloon manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Peripheral Drug-eluting Balloon Market Report

Report Metric	Details
Report Name	Peripheral Drug-eluting Balloon Market
Accounted market size in 2025	US$ 811 million
Forecasted market size in 2032	US$ 1775 million
CAGR	11.7%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Paclitaxel Others
Segment by Use Scenario	In-Stent Restenosi De Novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Lower Limbs Renal Artery Carotid Artery
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Peripheral Drug-eluting Balloon manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Peripheral Drug-eluting Balloon sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Peripheral Drug-eluting Balloon Market growing?

Ans: The Peripheral Drug-eluting Balloon Market witnessing a CAGR of 11.7% during the forecast period 2026-2032.

What is the Peripheral Drug-eluting Balloon Market size in 2032?

Ans: The Peripheral Drug-eluting Balloon Market size in 2032 will be US$ 1775 million.

Who are the main players in the Peripheral Drug-eluting Balloon Market report?

Ans: The main players in the Peripheral Drug-eluting Balloon Market are Medtronic, Boston Scientific, BD, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical

What are the Application segmentation covered in the Peripheral Drug-eluting Balloon Market report?

Ans: The Applications covered in the Peripheral Drug-eluting Balloon Market report are Lower Limbs, Renal Artery, Carotid Artery

What are the Type segmentation covered in the Peripheral Drug-eluting Balloon Market report?

Ans: The Types covered in the Peripheral Drug-eluting Balloon Market report are Paclitaxel, Others

1 Peripheral Drug-eluting Balloon Market Overview

1.1 Product Definition

1.2 Peripheral Drug-eluting Balloon by Type

1.2.1 Global Peripheral Drug-eluting Balloon Market Value by Type: 2025 vs 2032

1.2.2 Paclitaxel

1.2.3 Others

1.3 Peripheral Drug-eluting Balloon by Use Scenario

1.3.1 Global Peripheral Drug-eluting Balloon Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De Novo

1.3.4 Small Vessel

1.4 Peripheral Drug-eluting Balloon by Balloon Platform Mechanics

1.4.1 Global Peripheral Drug-eluting Balloon Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 Peripheral Drug-eluting Balloon by Application

1.5.1 Global Peripheral Drug-eluting Balloon Market Value by Application: 2025 vs 2032

1.5.2 Lower Limbs

1.5.3 Renal Artery

1.5.4 Carotid Artery

1.6 Global Peripheral Drug-eluting Balloon Market Size Estimates and Forecasts

1.6.1 Global Peripheral Drug-eluting Balloon Revenue 2021–2032

1.6.2 Global Peripheral Drug-eluting Balloon Sales 2021–2032

1.6.3 Global Peripheral Drug-eluting Balloon Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Peripheral Drug-eluting Balloon Market Competition by Manufacturers

2.1 Global Peripheral Drug-eluting Balloon Sales Market Share by Manufacturers (2021–2026)

2.2 Global Peripheral Drug-eluting Balloon Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Peripheral Drug-eluting Balloon Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Peripheral Drug-eluting Balloon, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Peripheral Drug-eluting Balloon, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Peripheral Drug-eluting Balloon, Product Types and Applications

2.7 Global Key Manufacturers of Peripheral Drug-eluting Balloon, Date of Entry into the Industry

2.8 Global Peripheral Drug-eluting Balloon Market Competitive Situation and Trends

2.8.1 Global Peripheral Drug-eluting Balloon Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Peripheral Drug-eluting Balloon Players Market Share by Revenue

2.8.3 Global Peripheral Drug-eluting Balloon Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Peripheral Drug-eluting Balloon Market Scenario by Region

3.1 Global Peripheral Drug-eluting Balloon Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Peripheral Drug-eluting Balloon Sales by Region: 2021–2032

3.2.1 Global Peripheral Drug-eluting Balloon Sales by Region: 2021–2026

3.2.2 Global Peripheral Drug-eluting Balloon Sales by Region: 2027–2032

3.3 Global Peripheral Drug-eluting Balloon Revenue by Region: 2021–2032

3.3.1 Global Peripheral Drug-eluting Balloon Revenue by Region: 2021–2026

3.3.2 Global Peripheral Drug-eluting Balloon Revenue by Region: 2027–2032

3.4 North America Peripheral Drug-eluting Balloon Market Facts & Figures by Country

3.4.1 North America Peripheral Drug-eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Peripheral Drug-eluting Balloon Sales by Country (2021–2032)

3.4.3 North America Peripheral Drug-eluting Balloon Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Peripheral Drug-eluting Balloon Market Facts & Figures by Country

3.5.1 Europe Peripheral Drug-eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Peripheral Drug-eluting Balloon Sales by Country (2021–2032)

3.5.3 Europe Peripheral Drug-eluting Balloon Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Peripheral Drug-eluting Balloon Market Facts & Figures by Region

3.6.1 Asia Pacific Peripheral Drug-eluting Balloon Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Peripheral Drug-eluting Balloon Sales by Region (2021–2032)

3.6.3 Asia Pacific Peripheral Drug-eluting Balloon Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Peripheral Drug-eluting Balloon Market Facts & Figures by Country

3.7.1 Latin America Peripheral Drug-eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Peripheral Drug-eluting Balloon Sales by Country (2021–2032)

3.7.3 Latin America Peripheral Drug-eluting Balloon Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Peripheral Drug-eluting Balloon Market Facts & Figures by Country

3.8.1 Middle East and Africa Peripheral Drug-eluting Balloon Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Peripheral Drug-eluting Balloon Sales by Country (2021–2032)

3.8.3 Middle East and Africa Peripheral Drug-eluting Balloon Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Peripheral Drug-eluting Balloon Sales by Type (2021–2032)

4.1.1 Global Peripheral Drug-eluting Balloon Sales by Type (2021–2026)

4.1.2 Global Peripheral Drug-eluting Balloon Sales by Type (2027–2032)

4.1.3 Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021–2032)

4.2 Global Peripheral Drug-eluting Balloon Revenue by Type (2021–2032)

4.2.1 Global Peripheral Drug-eluting Balloon Revenue by Type (2021–2026)

4.2.2 Global Peripheral Drug-eluting Balloon Revenue by Type (2027–2032)

4.2.3 Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021–2032)

4.3 Global Peripheral Drug-eluting Balloon Price by Type (2021–2032)

5 Segment by Application

5.1 Global Peripheral Drug-eluting Balloon Sales by Application (2021–2032)

5.1.1 Global Peripheral Drug-eluting Balloon Sales by Application (2021–2026)

5.1.2 Global Peripheral Drug-eluting Balloon Sales by Application (2027–2032)

5.1.3 Global Peripheral Drug-eluting Balloon Sales Market Share by Application (2021–2032)

5.2 Global Peripheral Drug-eluting Balloon Revenue by Application (2021–2032)

5.2.1 Global Peripheral Drug-eluting Balloon Revenue by Application (2021–2026)

5.2.2 Global Peripheral Drug-eluting Balloon Revenue by Application (2027–2032)

5.2.3 Global Peripheral Drug-eluting Balloon Revenue Market Share by Application (2021–2032)

5.3 Global Peripheral Drug-eluting Balloon Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Medtronic Peripheral Drug-eluting Balloon Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Boston Scientific

6.2.1 Boston Scientific Company Information

6.2.2 Boston Scientific Description and Business Overview

6.2.3 Boston Scientific Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Boston Scientific Peripheral Drug-eluting Balloon Product Portfolio

6.2.5 Boston Scientific Recent Developments/Updates

6.3 BD

6.3.1 BD Company Information

6.3.2 BD Description and Business Overview

6.3.3 BD Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 BD Peripheral Drug-eluting Balloon Product Portfolio

6.3.5 BD Recent Developments/Updates

6.4 Acotec

6.4.1 Acotec Company Information

6.4.2 Acotec Description and Business Overview

6.4.3 Acotec Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Acotec Peripheral Drug-eluting Balloon Product Portfolio

6.4.5 Acotec Recent Developments/Updates

6.5 Philips

6.5.1 Philips Company Information

6.5.2 Philips Description and Business Overview

6.5.3 Philips Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Philips Peripheral Drug-eluting Balloon Product Portfolio

6.5.5 Philips Recent Developments/Updates

6.6 Lepu Medical

6.6.1 Lepu Medical Company Information

6.6.2 Lepu Medical Description and Business Overview

6.6.3 Lepu Medical Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Lepu Medical Peripheral Drug-eluting Balloon Product Portfolio

6.6.5 Lepu Medical Recent Developments/Updates

6.7 Eurocor

6.7.1 Eurocor Company Information

6.7.2 Eurocor Description and Business Overview

6.7.3 Eurocor Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Eurocor Peripheral Drug-eluting Balloon Product Portfolio

6.7.5 Eurocor Recent Developments/Updates

6.8 MicroPort Medical

6.8.1 MicroPort Medical Company Information

6.8.2 MicroPort Medical Description and Business Overview

6.8.3 MicroPort Medical Peripheral Drug-eluting Balloon Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 MicroPort Medical Peripheral Drug-eluting Balloon Product Portfolio

6.8.5 MicroPort Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Peripheral Drug-eluting Balloon Industry Chain Analysis

7.2 Peripheral Drug-eluting Balloon Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Peripheral Drug-eluting Balloon Production Mode & Process Analysis

7.4 Peripheral Drug-eluting Balloon Sales and Marketing

7.4.1 Peripheral Drug-eluting Balloon Sales Channels

7.4.2 Peripheral Drug-eluting Balloon Distributors

7.5 Peripheral Drug-eluting Balloon Customer Analysis

8 Peripheral Drug-eluting Balloon Market Dynamics

8.1 Peripheral Drug-eluting Balloon Industry Trends

8.2 Peripheral Drug-eluting Balloon Market Drivers

8.3 Peripheral Drug-eluting Balloon Market Challenges

8.4 Peripheral Drug-eluting Balloon Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Boston Scientific

Acotec

List of Tables

Table 1. Global Peripheral Drug-eluting Balloon Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Peripheral Drug-eluting Balloon Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global Peripheral Drug-eluting Balloon Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global Peripheral Drug-eluting Balloon Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Peripheral Drug-eluting Balloon Market Competitive Situation by Manufacturers in 2025

Table 6. Global Peripheral Drug-eluting Balloon Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Peripheral Drug-eluting Balloon Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Peripheral Drug-eluting Balloon Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Peripheral Drug-eluting Balloon Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Peripheral Drug-eluting Balloon Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Peripheral Drug-eluting Balloon, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Peripheral Drug-eluting Balloon, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Peripheral Drug-eluting Balloon, Product Types and Applications

Table 14. Global Key Manufacturers of Peripheral Drug-eluting Balloon, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Peripheral Drug-eluting Balloon Companies by Tier (Tier 1, Tier 2, Tier 3), based on Peripheral Drug-eluting Balloon Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Peripheral Drug-eluting Balloon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Peripheral Drug-eluting Balloon Sales by Region (K Units), 2021–2026

Table 20. Global Peripheral Drug-eluting Balloon Sales Market Share by Region (2021–2026)

Table 21. Global Peripheral Drug-eluting Balloon Sales by Region (K Units), 2027–2032

Table 22. Global Peripheral Drug-eluting Balloon Sales Market Share by Region (2027–2032)

Table 23. Global Peripheral Drug-eluting Balloon Revenue by Region (US$ Million), 2021–2026

Table 24. Global Peripheral Drug-eluting Balloon Revenue Market Share by Region (2021–2026)

Table 25. Global Peripheral Drug-eluting Balloon Revenue by Region (US$ Million), 2027–2032

Table 26. Global Peripheral Drug-eluting Balloon Revenue Market Share by Region (2027–2032)

Table 27. North America Peripheral Drug-eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Peripheral Drug-eluting Balloon Sales by Country (K Units), 2021–2026

Table 29. North America Peripheral Drug-eluting Balloon Sales by Country (K Units), 2027–2032

Table 30. North America Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 31. North America Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Peripheral Drug-eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Peripheral Drug-eluting Balloon Sales by Country (K Units), 2021–2026

Table 34. Europe Peripheral Drug-eluting Balloon Sales by Country (K Units), 2027–2032

Table 35. Europe Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Peripheral Drug-eluting Balloon Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Peripheral Drug-eluting Balloon Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Peripheral Drug-eluting Balloon Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Peripheral Drug-eluting Balloon Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Peripheral Drug-eluting Balloon Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Peripheral Drug-eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Peripheral Drug-eluting Balloon Sales by Country (K Units), 2021–2026

Table 44. Latin America Peripheral Drug-eluting Balloon Sales by Country (K Units), 2027–2032

Table 45. Latin America Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Peripheral Drug-eluting Balloon Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Peripheral Drug-eluting Balloon Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Peripheral Drug-eluting Balloon Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Peripheral Drug-eluting Balloon Revenue by Country (US$ Million), 2027–2032

Table 52. Global Peripheral Drug-eluting Balloon Sales (K Units) by Type (2021–2026)

Table 53. Global Peripheral Drug-eluting Balloon Sales (K Units) by Type (2027–2032)

Table 54. Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2021–2026)

Table 55. Global Peripheral Drug-eluting Balloon Sales Market Share by Type (2027–2032)

Table 56. Global Peripheral Drug-eluting Balloon Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Peripheral Drug-eluting Balloon Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2021–2026)

Table 59. Global Peripheral Drug-eluting Balloon Revenue Market Share by Type (2027–2032)

Table 60. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Type (2021–2026)

Table 61. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Type (2027–2032)

Table 62. Global Peripheral Drug-eluting Balloon Sales (K Units) by Application (2021–2026)

Table 63. Global Peripheral Drug-eluting Balloon Sales (K Units) by Application (2027–2032)

Table 64. Global Peripheral Drug-eluting Balloon Sales Market Share by Application (2021–2026)

Table 65. Global Peripheral Drug-eluting Balloon Sales Market Share by Application (2027–2032)

Table 66. Global Peripheral Drug-eluting Balloon Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Peripheral Drug-eluting Balloon Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application (2021–2026)

Table 69. Global Peripheral Drug-eluting Balloon Revenue Market Share by Application (2027–2032)

Table 70. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Application (2021–2026)

Table 71. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Application (2027–2032)

Table 72. Medtronic Company Information

Table 73. Medtronic Description and Business Overview

Table 74. Medtronic Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Medtronic Peripheral Drug-eluting Balloon Product

Table 76. Medtronic Recent Developments/Updates

Table 77. Boston Scientific Company Information

Table 78. Boston Scientific Description and Business Overview

Table 79. Boston Scientific Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Boston Scientific Peripheral Drug-eluting Balloon Product

Table 81. Boston Scientific Recent Developments/Updates

Table 82. BD Company Information

Table 83. BD Description and Business Overview

Table 84. BD Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. BD Peripheral Drug-eluting Balloon Product

Table 86. BD Recent Developments/Updates

Table 87. Acotec Company Information

Table 88. Acotec Description and Business Overview

Table 89. Acotec Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Acotec Peripheral Drug-eluting Balloon Product

Table 91. Acotec Recent Developments/Updates

Table 92. Philips Company Information

Table 93. Philips Description and Business Overview

Table 94. Philips Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Philips Peripheral Drug-eluting Balloon Product

Table 96. Philips Recent Developments/Updates

Table 97. Lepu Medical Company Information

Table 98. Lepu Medical Description and Business Overview

Table 99. Lepu Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Lepu Medical Peripheral Drug-eluting Balloon Product

Table 101. Lepu Medical Recent Developments/Updates

Table 102. Eurocor Company Information

Table 103. Eurocor Description and Business Overview

Table 104. Eurocor Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Eurocor Peripheral Drug-eluting Balloon Product

Table 106. Eurocor Recent Developments/Updates

Table 107. MicroPort Medical Company Information

Table 108. MicroPort Medical Description and Business Overview

Table 109. MicroPort Medical Peripheral Drug-eluting Balloon Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. MicroPort Medical Peripheral Drug-eluting Balloon Product

Table 111. MicroPort Medical Recent Developments/Updates

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Peripheral Drug-eluting Balloon Distributors List

Table 115. Peripheral Drug-eluting Balloon Customers List

Table 116. Peripheral Drug-eluting Balloon Market Trends

Table 117. Peripheral Drug-eluting Balloon Market Drivers

Table 118. Peripheral Drug-eluting Balloon Market Challenges

Table 119. Peripheral Drug-eluting Balloon Market Restraints

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Authors List of This Report

List of Figures

Figure 1. Product Picture of Peripheral Drug-eluting Balloon

Figure 2. Global Peripheral Drug-eluting Balloon Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Peripheral Drug-eluting Balloon Market Share by Type: 2025 & 2032

Figure 4. Paclitaxel Product Picture

Figure 5. Others Product Picture

Figure 6. Global Peripheral Drug-eluting Balloon Market Value by Use Scenario (US$ Million), 2021–2032

Figure 7. Global Peripheral Drug-eluting Balloon Market Share by Use Scenario: 2025 vs 2032

Figure 8. In-Stent Restenosi Product Picture

Figure 9. De Novo Product Picture

Figure 10. Small Vessel Product Picture

Figure 11. Global Peripheral Drug-eluting Balloon Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 12. Global Peripheral Drug-eluting Balloon Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 13. Semi-/Compliant Product Picture

Figure 14. Non-compliant Product Picture

Figure 15. Other Product Picture

Figure 16. Global Peripheral Drug-eluting Balloon Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Peripheral Drug-eluting Balloon Market Share by Application: 2025 & 2032

Figure 18. Lower Limbs

Figure 19. Renal Artery

Figure 20. Carotid Artery

Figure 21. Global Peripheral Drug-eluting Balloon Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Peripheral Drug-eluting Balloon Market Size (US$ Million), 2021–2032

Figure 23. Global Peripheral Drug-eluting Balloon Sales (K Units), 2021–2032

Figure 24. Global Peripheral Drug-eluting Balloon Average Price (US$/Unit), 2021–2032

Figure 25. Peripheral Drug-eluting Balloon Report Years Considered

Figure 26. Peripheral Drug-eluting Balloon Sales Share by Manufacturers in 2025

Figure 27. Global Peripheral Drug-eluting Balloon Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Peripheral Drug-eluting Balloon Players: Market Share by Revenue in Peripheral Drug-eluting Balloon in 2025

Figure 29. Peripheral Drug-eluting Balloon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Peripheral Drug-eluting Balloon Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Peripheral Drug-eluting Balloon Sales Market Share by Country (2021–2032)

Figure 32. North America Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 33. U.S. Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Peripheral Drug-eluting Balloon Sales Market Share by Country (2021–2032)

Figure 36. Europe Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 37. Germany Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Peripheral Drug-eluting Balloon Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Peripheral Drug-eluting Balloon Revenue Market Share by Region (2021–2032)

Figure 44. China Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Taiwan Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Indonesia Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Thailand Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Malaysia Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Philippines Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Latin America Peripheral Drug-eluting Balloon Sales Market Share by Country (2021–2032)

Figure 55. Latin America Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 56. Mexico Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Brazil Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Argentina Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Middle East and Africa Peripheral Drug-eluting Balloon Sales Market Share by Country (2021–2032)

Figure 60. Middle East and Africa Peripheral Drug-eluting Balloon Revenue Market Share by Country (2021–2032)

Figure 61. Turkey Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Saudi Arabia Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. U.A.E Peripheral Drug-eluting Balloon Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. Global Sales Market Share of Peripheral Drug-eluting Balloon by Type (2021–2032)

Figure 65. Global Revenue Market Share of Peripheral Drug-eluting Balloon by Type (2021–2032)

Figure 66. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Type (2021–2032)

Figure 67. Global Sales Market Share of Peripheral Drug-eluting Balloon by Application (2021–2032)

Figure 68. Global Revenue Market Share of Peripheral Drug-eluting Balloon by Application (2021–2032)

Figure 69. Global Peripheral Drug-eluting Balloon Price (US$/Unit) by Application (2021–2032)

Figure 70. Peripheral Drug-eluting Balloon Value Chain

Figure 71. Channels of Distribution (Direct Vs Distribution)

Figure 72. Bottom-up and Top-down Approaches for This Report

Figure 73. Data Triangulation

Figure 74. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Peripheral Balloon Market Research Report 2024

Drug Eluting Balloon Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peripheral Intervention Drug Eluting Devices Market Insights Forecast to 2030

Global Drug eluting PTA Balloon Dilatation Catheter Market Research Report 2025

Global Balloon Catheter Market Research Report 2024

Global PTCA Coronary Drug Eluting Balloons Market Research Report 2024

Global Coronary Artery Scoring Balloon Market Research Report 2024

Global Occlusion Balloon Catheter Market Research Report 2025

Global Drug Eluting Peripheral Stents Market Research Report 2025

Global Intracardiac Drug Coated Balloons Market Research Report 2025

Global Advanced Balloon Catheter Market Research Report 2024

Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2024

Global Peripheral Arterial Interventional Devices Market Research Report 2025

Global Cardiac Drug Balloon Market Research Report 2025

Global Drug Coated PTA Balloon Catheter Market Research Report 2024

Balloon Angioplasty and Heart Stents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balloon expandable Stents Market Research Report 2024

Peripheral Vascular Embolic Protection Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peripheral Catheters Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions